Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell - 9-MTH group results

Feb 12 (Reuters)- 
             Reprocell Incorporated 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2020        Dec 31, 2019      Mar 31, 2021  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            949 mln             891 mln            1.30      
                 (+6.5 pct)          (+10.6 pct)       (+8.0 pct)   
  Operating     loss 764 mln        loss 671 mln        loss 1.04   
  Recurring     loss 657 mln        loss 656 mln      loss 893 mln  
  Net           loss 658 mln        loss 663 mln      loss 893 mln  
  EPS           loss 9.22 yen       loss 9.32 yen    loss 12.52 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Reprocell Incorporated. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T

Recent news on ReproCELL Incorporated

See all news